KALAB
Kala Bio to conduct 1-for-30 reverse stock split on Nov. 13, 2026
Kala Bio shareholders approved a reverse stock split effective November 13, 2026, converting each 30 shares of common stock into one share. This move is necessary to meet Nasdaq listing requirements.